Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

troy laboratories pty ltd - trimethoprim; sulfadimidine - oral powder, pre-mix - trimethoprim pyrimidine active 86.0 mg/g; sulfadimidine sulfanyl active 430.0 mg/g - antibiotic & related - calf | horse | pigs | poultry | beef calf | boar | bovine | breeders | broiler | calf - poddy | calf - preweaning | calf - sucke - bacterial infection | brucella spp. | corynebacterium - exclusions see label | enterobacter spp. | escherichia coli (e. coli) | fusobacterium spp. | haemophilus spp. | klebsiella spp. | nocardia spp. | organisms sensitive to combination of | pasteurella spp. | proteus spp. | pseudomonas spp. | salmonella | shigella spp. | staphylococci | streptococci | amoxycillin sensitive bacteria | anaerobic bacteria | associated with viral disease | bacterial canker | brucella abortus | brucella melitensis | brucella suis | gram negative organisms | gram positive organisms | haemophilus agni | haemophilus bovis | haemophilus parainfluenzae | haemophilus parasuis | haemophilus pleuropneumoniae | haemophilus somnus | haemophilus suis | including b-lactamase producin | pasterellosis | pasteurellosis | post parturient bacterial infe | primary bacterial infection | salmonellosis | sulfadiazine sensitive bacteri | trimethoprim sensitive bacteri | tylosin sensitive bacteria

Australia - English - Department of Health (Therapeutic Goods Administration)

seqirus pty ltd - vibrio cholerae, quantity: 31.25 billion organisms; vibrio cholerae, quantity: 1 mg - oral liquid, suspension - excipient ingredients: sodium chloride; dibasic sodium phosphate dihydrate; water for injections; monobasic sodium phosphate dihydrate - cholera caused by serogroup 01 vibrio cholerae: active immunisation of adults and children from two years of age, who will be visiting areas epidemic or endemic for cholera and who are at high risk of infection.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

kent pharma (uk) ltd - amoxicillin trihydrate - powder - 3gram

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra veterinary products a/s - phenylbutazone - oral powder - 1 grams - phenylbutazone - equine non food - n.s.a.i.d

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra veterinary products a/s - phenylbutazone - oral powder - 1.0 g/sachet - phenylbutazone - non food-producing horses - n.s.a.i.d.

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - phenylbutazone - oral powder - 1.0 gram(s) - phenylbutazone

Australia - English - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - ticarcillin sodium, quantity: 3.3 g (equivalent: ticarcillin, qty 3 g); potassium clavulanate, quantity: 119.2 g (equivalent: clavulanic acid, qty 100 mg) - injection, powder for - excipient ingredients: - timentin is indicated in the treatment of serious infections caused by susceptible strains of beta-lactamase producing organisms in the conditions listed below: septicaemia (and bacteraemia) cases caused by beta-lactamase producing organisms including strains of klebsiella pneumoniae, e.coli, staphylococcus aureus and pseudomonas aeruginosa. lower respiratory infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus, haemophilus influenzae and klebsiella pneumoniae. bone and joint infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus. skin and skin structure infections cases caused by beta-lactamase producing susceptible organisms including strains of staphylococcus aureus, klebsiella pneumoniae and e. coli. urinary tract infections cases caused by beta-lactamase producing susceptible organisms including strains of e.coli, klebsiella pneumoniae, pseudomonas aeruginosa and staphylococcus au

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

rufus & coco pty. ltd. - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 180.0 m cfu/g; enterococcus faecium biological-organism active 180.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 180.0 m cfu/g; lactobacillus acidophilus biological-organism active 180.0 m cfu/g; lactobacillus plantarum biological-organism active 180.0 m cfu/g; lactobacillus rhamnosus biological-organism active 180.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 180.0 m cfu/g - nutrition & metabolism - animal | birds | dog - puppy | kitten | aviary bird | breeders | broilers | budgerigars | canaries | chickens | chooks | domesti - diarrhoea | intestinal dysfunction | re-establishment of gut microflora | stress | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | following antibiotic use | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | post-antibiotic therapy | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

international animal health products pty ltd - bifidobacterium bifidum; enterococcus faecium; lactobacillus delbrueckii subspecies bulgaricus; lactobacillus acidophilus; lactobacillus plantarum; lactobacillus rhamnosus; streptococcus salivarius subspecies thermophilus - oral powder, pre-mix - bifidobacterium bifidum biological-organism active 60.0 m cfu/g; enterococcus faecium biological-organism active 60.0 m cfu/g; lactobacillus delbrueckii subspecies bulgaricus biological-organism active 60.0 m cfu/g; lactobacillus acidophilus biological-organism active 60.0 m cfu/g; lactobacillus plantarum biological-organism active 60.0 m cfu/g; lactobacillus rhamnosus biological-organism active 60.0 m cfu/g; streptococcus salivarius subspecies thermophilus biological-organism active 60.0 m cfu/g - nutrition & metabolism - animal | birds | cage birds | calf | cat | cattle | dog | dog - puppy | goat | goat kid | horse | horse foal | kitten | lamb | p - establishment of gut microflora | intestinal dysfunction | productivity improvements | promote animal growth | reduced mortality | re-establishment of gut microflora | feed conversion | finishing | following antibiotic use | growth promotion | growth rate | improving feed efficiency | increasing rate of weight gain | liveweight gain | post-antibiotic therapy

Australia - English - Department of Health (Therapeutic Goods Administration)

roche products pty ltd - mycophenolate mofetil, quantity: 500 mg - injection, powder for - excipient ingredients: polysorbate 80; sodium hydroxide; citric acid; hydrochloric acid - cellcept is indicated for the prophylaxis of solid organ rejection in adults receiving allogeneic organ transplants. cellcept is indicated for the prophylaxis of organ rejection in paediatric patients (2 to 18 years) receiving allogeneic renal transplants.